A Non- Interventional Study to Observe Real Life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,076
- 试验地点
- 1
- 主要终点
- Use of atypical antipsychotic(s) during hospitalisation.
研究概览
简要总结
The primary objective of this Non- Interventional Study (NIS) is to describe the use of atypical antipsychotics in subjects with Schizophrenia during the hospitalisation due to acute psychotic episode by evaluation of drug, dose and mode of administration of the medication.
详细描述
RECONNECT-S BETA
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meet the diagnostic criteria for schizophrenia stated in The Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria.
- •Subject is hospitalised due to an acute psychotic episode.
- •Ability of the subject to understand and comply with the requirements of the study, as judged by the investigator.
排除标准
- •Current participation in any clinical trial.
- •Previous enrolment in the present NIS (in case of recurrence occurred during the enrolment period).
结局指标
主要结局
Use of atypical antipsychotic(s) during hospitalisation.
时间窗: Hospitalisation period, an expected average of 3 weeks (variable per patient).
The data will be collected at one visit at the moment of discharge from the hospital.
Daily dosage of atypical antipsychotic(s) during hospitalisation.
时间窗: Hospitalisation period, an expected average of 3 weeks (variable per patient).
The data will be collected at one visit at the moment of discharge from the hospital.
Mode of administration of atypical antipsychotic(s) during hospitalisation.
时间窗: Hospitalisation period, an expected average of 3 weeks (variable per patient).
The data will be collected at one visit at the moment of discharge from the hospital.
次要结局
- Main criteria of an antipsychotic's selection during hospitalisation expressed as percentage.(Hospitalisation period, an expected average of 3 weeks (variable per patient).)
- Use of psychometric scales in day to day practice in therm of evaluation of the disease symptoms and thus efficacy of the treatment.(Hospitalisation period, an expected average of 3 weeks (variable per patient).)
- Percent of patients with atypical antipsychotic as monotherapy.(Hospitalisation period, an expected average of 3 weeks (variable per patient).)
- Percent of patients with combinations of antipsychotics.(Hospitalisation period, an expected average of 3 weeks (variable per patient).)
- Description of the usage of concomitant psychiatric medication (other than atypical antipsychotic) during the hospitalization.(Hospitalisation period, an expected average of 3 weeks (variable per patient).)
- Relationship between medication used during the hospitalization and maintenance therapy recommended upon discharge.(Hospitalisation period, an expected average of 3 weeks (variable per patient).)